Screener
West Pharmaceutical Services WST Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Income before income taxes and equity in net income of affiliated companies | 180.1 | 157.0 | 360.2 | 267.5 |
| Income tax expense | 32.2 | 30.2 | 76.9 | 54.3 |
| Equity in net income of affiliated companies | (6.1) | (5.0) | (9.5) | (8.4) |
| Net income | $154.0 | $131.8 | $292.8 | $221.6 |
| Net income per share: | ||||
| Basic | $2.17 | $1.82 | $4.10 | $3.06 |
| Diluted | $2.15 | $1.82 | $4.07 | $3.05 |
| Weighted average shares outstanding: |
Item 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is West Pharmaceutical Services's net income?
- West Pharmaceutical Services (WST) reported net income of $154M in Q2 2026.
- How has West Pharmaceutical Services's net income changed year-over-year?
- West Pharmaceutical Services's net income increased by 16.8% year-over-year, from $131.8M to $154M.
- What is the long-term trend for West Pharmaceutical Services's net income?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's net income has grown at a -7.1% compound annual growth rate (CAGR), from $661.8M to $493.7M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about West Pharmaceutical Services's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude